[HTML][HTML] A medicinal chemist's guide to molecular interactions

C Bissantz, B Kuhn, M Stahl - Journal of medicinal chemistry, 2010 - ACS Publications
C−X axis is distorted toward carbon, forming the C−X single bond. This leads to attractive
interactions between C… -bond acceptors, with a preference for linear C−X···B arrangements. For …

Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations

C Bissantz, G Folkers, D Rognan - Journal of medicinal chemistry, 2000 - ACS Publications
… Its phenolic group has clearly rotated around the Csp2-C.ar bond with respect to the
conformationally rigidified naphthol analogue (LY-357489) and could not be accommodated in the …

Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin …

…, D Rognan, C Bissantz, C Hinderling… - Journal of medicinal …, 2002 - ACS Publications
… To assess the acid lability of the albumin conjugate of 3, the conjugate was incubated at
pH 5.0 at 37 C and analyzed over a period of 3 h on a C-18 reverse-phase column. The initial …

Can we discover pharmacological promiscuity early in the drug discovery process?

JU Peters, J Hert, C Bissantz, A Hillebrecht… - Drug Discovery …, 2012 - Elsevier
… Similarly, Roche and Pfizer found that maximum promiscuity among their project compounds
was observed for a threshold c log P higher than 2.5–3 19, 21. These findings add to the …

Protein‐based virtual screening of chemical databases. II. Are homology models of G‐protein coupled receptors suitable targets?

C Bissantz, P Bernard, M Hibert… - … : Structure, Function, and …, 2003 - Wiley Online Library
The aim of the current study is to investigate whether homology models of G‐Protein‐Coupled
Receptors (GPCRs) that are based on bovine rhodopsin are reliable enough to be used …

[HTML][HTML] A novel antibiotic class targeting the lipopolysaccharide transporter

…, C Bieniossek, C Bissantz, F Boess, C Cantrill… - Nature, 2024 - nature.com
… b,c, The in vivo efficacy of RO7075573 in a mouse model of infection induced by A. baumannii
ACC00535 (… c, Thigh infection was induced by bacterial intramuscular inoculation in …

A real-world perspective on molecular design: Miniperspective

…, W Guba, J Hert, D Banner, C Bissantz… - Journal of medicinal …, 2016 - ACS Publications
We present a series of small molecule drug discovery case studies where computational
methods were prospectively employed to impact Roche research projects, with the aim of …

Conformational changes of G protein‐coupled receptors during their activation by agonist binding

C Bissantz - Journal of receptors and signal transduction, 2003 - Taylor & Francis
… They additionally share N‐linked glycosylation sites in the N‐terminal extracellular domain
and phosphorylation and palmitoylation sites at the C‐terminal intracellular domain. The …

Safety screening in early drug discovery: an optimized assay panel

S Bendels, C Bissantz, B Fasching, G Gerebtzoff… - … of pharmacological and …, 2019 - Elsevier
… Roche compounds producing ≥50% inhibition at 10 μM (column C) were classified as a
hit in Roche assay targets. However, during the target selection process, where increased …

High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening

C Bissantz, A Logean, D Rognan - Journal of chemical information …, 2004 - ACS Publications
… acid a at position c, b ca . the pseudocount for amino acid a at position c, N c the total number
of counts, and B c the total number of pseudocounts at position c. The pseudocount b ca . …